| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.29B | 43.09B | 39.71B | 49.38B | 56.76B | 43.51B |
| Gross Profit | 8.13B | 8.49B | 7.59B | 12.37B | 18.82B | 12.23B |
| EBITDA | 6.72B | 6.99B | 5.90B | 8.91B | 17.54B | 10.01B |
| Net Income | 2.71B | 1.63B | 2.06B | 3.66B | 10.78B | 4.70B |
Balance Sheet | ||||||
| Total Assets | 103.67B | 97.78B | 98.97B | 97.29B | 103.82B | 93.25B |
| Cash, Cash Equivalents and Short-Term Investments | 13.42B | 10.84B | 12.99B | 11.40B | 10.07B | 9.36B |
| Total Debt | 24.93B | 21.71B | 22.93B | 19.76B | 18.42B | 17.24B |
| Total Liabilities | 36.27B | 33.05B | 34.53B | 32.60B | 35.13B | 32.45B |
| Stockholders Equity | 62.56B | 59.82B | 59.74B | 60.06B | 63.02B | 55.86B |
Cash Flow | ||||||
| Free Cash Flow | 2.61B | 1.54B | 1.18B | 5.29B | 5.58B | 7.83B |
| Operating Cash Flow | 6.69B | 5.76B | 5.31B | 10.58B | 9.50B | 9.50B |
| Investing Cash Flow | -4.20B | -1.51B | -8.24B | -5.33B | -6.01B | 2.76B |
| Financing Cash Flow | -2.54B | -3.56B | 622.28M | -3.77B | -4.67B | -12.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$23.16B | 5.79 | 6.18% | 5.00% | 7.45% | 11.56% | |
71 Outperform | HK$16.25B | 6.14 | 5.58% | 6.37% | -7.44% | -18.48% | |
69 Neutral | HK$33.98B | 12.56 | 4.43% | 5.88% | 6.95% | 24.07% | |
66 Neutral | HK$44.08B | 7.60 | 6.26% | 4.94% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | HK$161.18M | 17.31 | 0.53% | ― | -9.32% | ― | |
42 Neutral | HK$33.56B | -7.00 | -3.65% | 0.44% | -8.93% | -698.78% |